Australian Pharma Industries(API.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

API.AU Australian Pharma Industries

Market Closed 04-11 16:00:00 AEST

1.53

+0.00

0.00%

High1.53	Low1.53	Vol0.00
Open1.53	D1 Closing1.53	Amplitude0.00%
Mkt Cap753.76M	Tradable Cap607.28M	Total Shares492.66M
T/O5.18M	T/O Rate0.00%	Tradable Shares396.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"API.AU","market":"AU","secType":"STK","nameCN":"Australian Pharma Industries","latestPrice":1.53,"timestamp":1744351200000,"preClose":1.53,"halted":0,"volume":0,"delay":0,"nameEN":"Australian Pharma Industries","floatShares":396917399,"shares":492656035,"eps":0.002795,"marketStatus":"Market Closed","change":0,"latestTime":"04-11 16:00:00 AEST","open":1.53,"high":1.53,"low":1.53,"amount":5184735.1000092,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.002795,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1744588800000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":1.53,"dividendRate":0.022876,"openAndCloseTimeList":[[1744329600000,1744351200000]],"volumeRatio":1.318654687580577,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/API.AU","defaultTab":"news","newsList":[{"id":"2524237249","title":"Jiangsu Sinopep-Allsino Biopharmaceutical Gets EU Export Nod for Type 2 Diabetes Drug API","url":"https://stock-news.laohu8.com/highlight/detail?id=2524237249","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524237249?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 19:00","pubTimestamp":1743678015,"startTime":"0","endTime":"0","summary":"Jiangsu Sinopep-Allsino Biopharmaceutical  obtained approval to export tirzepatide as an active pharmaceutical ingredient  to the European Union, according to a Thursday filing with the Shanghai Stock Exchange.Sinopep-Allsino's factory in Lianyungang passed the EU's good manufacturing practice compliance for export, the filing said.Tirzepatide is indicated for type 2 diabetes.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7103","BK4551","BK4503","API","BK4156","BK6520","688076","BK4023","BK4535","BK0239","OTX.SI","API.AU","BK6100"],"gpt_icon":0},{"id":"2518740348","title":"Viking & CordenPharma partner to boost VK2735 production","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740348","media":"Grafa","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740348?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 22:20","pubTimestamp":1741702853,"startTime":"0","endTime":"0","summary":"Viking Therapeutics  has announced a significant multi-year manufacturing agreement with CordenPharma, a leading contract development and manufacturing organization , to ensure long-term supply for its promising obesity drug, VK2735.This deal positions Viking to meet anticipated high demand for both subcutaneous and oral formulations of the drug, potentially a multi-billion-dollar annual product.The agreement secures dedicated manufacturing capacity for multiple metric tons of VK2735 active pharmaceutical ingredient  annually.CordenPharma will also handle the fill/finish process, committing to supply 100 million autoinjectors and 100 million vial and syringe products for the injectable version, as well as over one billion oral tablets annually.\"We are excited to enter into this agreement with one of the world’s leading CDMOs in the peptide space,\" said Brian Lian, Ph.D., chief executive officer of Viking Therapeutics.\"CordenPharma’s established presence in commercial peptide manufactur","market":null,"thumbnail":"https://images.grafa.com/grafa/media-health-viking---cordenpharma-partner-to-boost-vk2735-production-395048-638772996533234075.jpeg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-health-viking---cordenpharma-partner-to-boost-vk2735-production-395048-638772996533234075.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/health-viking---cordenpharma-partner-to-boost-vk2735-production-395048?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7103","API.AU"],"gpt_icon":0},{"id":"2518829472","title":"Hunan Warrant Pharmaceutical to Invest Up to 500 Million Yuan in API Manufacturing Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2518829472","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518829472?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 16:07","pubTimestamp":1741594054,"startTime":"0","endTime":"0","summary":"Hunan Warrant Pharmaceutical (SHA:688799) is planning to invest up to 500 million yuan in the phase two expansion of its high-end active pharmaceutical ingredient (API) and intermediate green manufact","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","API.AU","BK4551","BK7103","BK4023","BK4535","BK6100","BK6520","API","688799","BK4503","BK0239"],"gpt_icon":0},{"id":"2514346627","title":"Guobang Pharma Subsidiary Gains Approval for Domestic Production of Cefuroxime Axetil API","url":"https://stock-news.laohu8.com/highlight/detail?id=2514346627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514346627?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 17:46","pubTimestamp":1740735996,"startTime":"0","endTime":"0","summary":"Guobang Pharma's  subsidiary, Zhejiang Dongying, received approval from China's National Medical Products Administration to domestically produce its Cefuroxime Axetil Active Pharmaceutical Ingredient , according to a Friday filing with the Shanghai Bourse.The antibiotic treats respiratory, skin, and gonococcal infections. The API is also certified by the European EDQM.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK4503","BK0239","BK6520","API.AU","605507","API","BK4535","BK4551","OTX.SI","BK6100","BK7103"],"gpt_icon":0},{"id":"2513126870","title":"Zhejiang Jianfeng Group Unit Secures Approval for API Market Entry","url":"https://stock-news.laohu8.com/highlight/detail?id=2513126870","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513126870?lang=en_us&edition=full_marsco","pubTime":"2025-02-21 18:38","pubTimestamp":1740134287,"startTime":"0","endTime":"0","summary":"Zhejiang Jianfeng Group (SHA:600668) subsidiary Jianfeng Pharmaceutical obtained approval from China's drug administrator for active pharmaceutical ingredient (API) roxadustat.The approval is expected to expand the company's business scope, according to a Friday filing with the Shanghai bourse.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","OTX.SI","BK0235","BK0186","600668","BK0188","BK4503","BK4551","API","BK4535","BK6100","API.AU","BK6520","BK7103"],"gpt_icon":0},{"id":"2513237362","title":"Jiangxi Synergy Pharmaceutical Secures Drug Registration in South Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2513237362","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513237362?lang=en_us&edition=full_marsco","pubTime":"2025-02-21 15:18","pubTimestamp":1740122304,"startTime":"0","endTime":"0","summary":"Jiangxi Synergy Pharmaceutical  said it received a drug registration certificate from South Korea's Ministry of Food and Drug Safety  for its empagliflozin active pharmaceutical ingredient , used in treating type 2 diabetes, according to a Wednesday filing with the Shenzhen Bourse.This approval grants the company market access in South Korea, supporting its international expansion. The certification was issued on Feb. 18.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7103","API.AU","BK4023","BK4535","API","BK4503","BK4551","BK0239","300636"],"gpt_icon":0},{"id":"2510879059","title":"Sinopep-Allsino Biopharmaceutical Passes GMP Inspections for APIs in South Korea, China","url":"https://stock-news.laohu8.com/highlight/detail?id=2510879059","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510879059?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 16:01","pubTimestamp":1739260870,"startTime":"0","endTime":"0","summary":"Jiangsu Sinopep-Allsino Biopharmaceutical  received good manufacturing practice compliance certifications from South Korea and China's Jiangsu province.These are semaglutide and fulvestrant active pharmaceutical ingredients  for export to South Korea as well as epalrestat and sodium picosulfate APIs for domestic production, according to a Tuesday filing with the Shanghai bourse.Shares of the biopharmaceutical company were down 3% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","688076","BK4535","API","BK4023","BK7103","API.AU","BK0239","BK4503"],"gpt_icon":0},{"id":"2508101410","title":"Crypto liquidations estimated at $10 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2508101410","media":"Grafa","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508101410?lang=en_us&edition=full_marsco","pubTime":"2025-02-04 11:06","pubTimestamp":1738638386,"startTime":"0","endTime":"0","summary":"The recent downturn in the cryptocurrency market may have led to liquidations totaling up to $10 billion, reaching over earlier estimates, according to Bybit CEO Ben Zhou.On February 3, over $2.24 billion was liquidated from the crypto markets within just 24 hours, as reported by CoinGlass.“Bybit’s 24hr liquidation alone was $2.1 billion,” Zhou stated in a post, and he estimated that the total liquidations could be between $8 billion and $10 billion.This significant liquidation event occurred amid rising macroeconomic concerns following President Donald Trump’s announcement of new tariffs on goods from China, Canada, and Mexico.These tariffs have sparked fears of a potential global trade war, which has negatively impacted investor sentiment across various markets.Zhou explained that discrepancies in liquidation figures are likely due to limitations in the application programming interfaces  of cryptocurrency exchanges.The liquidation event affected over 730,000 traders, with the larges","market":null,"thumbnail":"https://images.grafa.com/grafa/media-cryptocurrencies-crypto-liquidations-estimated-at--10-billion-364946-638742351868934619.jpeg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-cryptocurrencies-crypto-liquidations-estimated-at--10-billion-364946-638742351868934619.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/cryptocurrencies-crypto-liquidations-estimated-at--10-billion-364946?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TON.USD.CC","BK7103","API.AU","TON.USD.HKCC","APT.USD.HKCC","APT.USD.CC"],"gpt_icon":0},{"id":"2506353430","title":"\"Nvidia's still a buy\": As China's ChatGPT moment rattles tech sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2506353430","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506353430?lang=en_us&edition=full_marsco","pubTime":"2025-01-28 08:33","pubTimestamp":1738024421,"startTime":"0","endTime":"0","summary":"The 17% plunge in Nvidia shares overnight is 'wildly overdone' as it changes almost nothing around the fundamental growth outlook for the chip manufacturer, according to Theo Mass, portfolio manager at Northcape Capital.The tech investing guru said China's Deepseek is a large language model  that focuses on the training phase of artificial intelligence , but the long-term growth market for AI remains the inference phase where trained models learn patterns to create predictions and offer solutions.\"My biggest point would be keep your eyes on the prize more than anything else,\" said Mr Maas. \"The biggest game in town that these guys  are going after is still inference AI over the next five to 10 years.\". Mr Maas said Northcape Capital still owns Nvidia shares and is bullish on its outlook. However, panicked investors wiped $US600 billion from its valuation on Monday around worries Deepseek will lower future demand for Nvidia's graphic processing units .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/nvidia-s-still-a-buy-as-china-s-chatgpt-moment-rattles-tech-sector","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/nvidia-s-still-a-buy-as-china-s-chatgpt-moment-rattles-tech-sector","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["NVDS.UK","AMD","NVDX","LU0109391861.USD","DDOG","NVDA","NVDU","LU1989772923.USD","SNVD.UK","TQQQ","QID","NVD","LU0795875086.SGD","AGI","LU1366192091.USD","AGI.AU","LU0316494557.USD","LU0323591593.USD","NVIW.SI","3NVD.UK","NQmain","PSQ",".IXIC","SQQQ","API","NVD3.UK","NVDS","USAW.SI","WDAY","LU0345770993.USD","QLD","MNQmain","LU0203347892.USD","LU2491050154.USD","USJW.SI","API.AU","AVGO","LU0096364046.USD","NVD2.UK","BK4598","LU1868836914.USD","NVDD","CRWD","TSYW.SI","ADBE","LU1551013342.USD","2NVD.UK","NVDY"],"gpt_icon":1},{"id":"2503916068","title":"Asian Equities Traded in the US as American Depositary Receipts Advance in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916068","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503916068?lang=en_us&edition=full_marsco","pubTime":"2025-01-16 23:36","pubTimestamp":1737041786,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher Thursday morning, up 0.3% to 2,083.58 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by live streaming platform Douyu  and software company Agora , which jumped 29% and 18% respectively. They were followed by live streaming platform Huya  and chipmaker Taiwan Semiconductor , which climbed 11% and 5.4% respectively.The decliners from North Asia were led by education companies TCTM Kids IT Education  and Ambow Education , which dropped 20% and 16% respectively.From South Asia, the gainers were led by tech conglomerate Sea , which rose 1%.The decliners from South Asia were led by pharmaceutical company Dr Reddy's Laboratories , which fell 3.7%, followed by tech companies Wipro , which was down 3.4%, and Infosys , which was shedding 1.5%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B7N09G41.SGD","HUYA","SG9999000418.SGD","LU0231203729.USD","03145","LU1868837565.USD","LU0541502299.USD","TCTM","SE","LU2125154935.USD","LU0109392836.USD","LU0823414478.USD","SG9999002620.SGD","BK4526","SG9999002679.SGD","LU2294711713.HKD","BK4596","LU2054465674.USD","LU2458330243.SGD","RDY","RDY.AU","BK4085","AMBO","LU0353189680.USD","BK4585","LU0791590937.USD","SG9999001135.SGD","LU2250418816.HKD","LU1282649067.USD","WIT","INFY","LU2125154778.USD","LU0823414551.USD","LU2506951792.HKD","AFG","DOYU","LU2237443978.SGD","LU0823421416.USD","IE00BQXX3F31.USD","TSM","BK4591","LU0889566641.SGD","BK4557","SG9999004220.SGD","SG9999014484.SGD","API.AU","BK4512","LU1508157978.USD","API","LU0572939691.SGD"],"gpt_icon":1},{"id":"2503738669","title":"JiangSu WuZhong Pharmaceutical Development Gets Registration for Eperisone Hydrochloride API","url":"https://stock-news.laohu8.com/highlight/detail?id=2503738669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503738669?lang=en_us&edition=full_marsco","pubTime":"2025-01-15 14:22","pubTimestamp":1736922125,"startTime":"0","endTime":"0","summary":"JiangSu WuZhong Pharmaceutical Development (SHA:600200) secured registration approval for eperisone hydrochloride active pharmaceutical ingredient (API) from China's drug regulator.Eperisone hydrochlo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","BK7103","OTX.SI","API.AU","BK4503","BK4023","BK0188","BK0239","BK6100","BK0060","BK6520","API","BK0012","BK0028","BK4535","600200"],"gpt_icon":0},{"id":"2503514909","title":"Tianyao Pharmaceuticals Gets China Registration Approval for Formoterol API","url":"https://stock-news.laohu8.com/highlight/detail?id=2503514909","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503514909?lang=en_us&edition=full_marsco","pubTime":"2025-01-14 15:36","pubTimestamp":1736840165,"startTime":"0","endTime":"0","summary":"Tianjin Tianyao Pharmaceuticals (SHA:600488) secured registration approval for formoterol fumarate active pharmaceutical ingredient (API) from China's drug administrator.Formoterol fumarate is used to","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6100","API","BK4023","OTX.SI","BK0239","API.AU","BK0012","BK0028","BK4503","600488","BK4535","BK0102","BK4551","BK7103","BK6520"],"gpt_icon":0},{"id":"2503329545","title":"Zhejiang Cheng Yi Pharmaceutical Passes TGA-GMP Certification for Two APIs","url":"https://stock-news.laohu8.com/highlight/detail?id=2503329545","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503329545?lang=en_us&edition=full_marsco","pubTime":"2025-01-13 15:38","pubTimestamp":1736753897,"startTime":"0","endTime":"0","summary":"Zhejiang Cheng Yi Pharmaceutical  passed Australia's Therapeutic Goods Administration-Good Manufacturing Practice certification for two active pharmaceutical ingredients .Azathioprine API is mainly used for immunosuppression and treating tumors, while mercaptopurine API is an anti-tumor compound, according to a Jan. 10 filing with the Shanghai bourse.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","BK4535","API","BK7103","BK4503","603811","BK6100","XKO.AU","API.AU","BK4213","TGA","XAO.AU","XJO.AU","BK4023","BK6520","BK0239","BK4551"],"gpt_icon":0},{"id":"2500916494","title":"Tianjin Tianyao Pharmaceuticals Gets Listing Approval for Dexamethasone Sodium Phosphate API in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2500916494","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500916494?lang=en_us&edition=full_marsco","pubTime":"2025-01-02 15:55","pubTimestamp":1735804544,"startTime":"0","endTime":"0","summary":"Tianjin Tianyao Pharmaceuticals (SHA:600488) secured registration approval for dexamethasone sodium phosphate active pharmaceutical ingredient (API) from Brazil's health surveillance agency.Dexamethas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OTX.SI","5WV.SI","API.AU","BK4551","BK7103","BK0102","BK0028","BK4023","BK0012","600488","BK4535","BK6031","BK6100","API","BK6520","BK4503","BK6501","BK0239"],"gpt_icon":0},{"id":"2488674051","title":"Sector Update: Tech Stocks Mixed Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2488674051","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488674051?lang=en_us&edition=full_marsco","pubTime":"2024-12-02 22:06","pubTimestamp":1733148376,"startTime":"0","endTime":"0","summary":"Technology stocks were mixed premarket Monday as the Technology Select Sector SPDR Fund (XLK) was down 0.1% and the SPDR S&P Semiconductor ETF (XSD) was up 0.9% recently.Agora (API) shares rose past 4","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","API","LSPD","BK4123","BK4588","API.AU","BK4535","BK4023","BK7103","XLK","XSD","BK4551","BK4503","NOTE"],"gpt_icon":1},{"id":"2488739516","title":"Agora Senior Management Team Signs Voluntary Lock-Up Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488739516","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488739516?lang=en_us&edition=full_marsco","pubTime":"2024-12-02 20:17","pubTimestamp":1733141852,"startTime":"0","endTime":"0","summary":"Agora  said Monday that its senior management team voluntarily entered into a lock-up period for company shares owned by them and entities they control.The management team includes Chief Executive Officer Bin Zhao and Chief Financial Officer Jingbo Wang, among others.According to the company, the group agreed not to sell any Agora shares through Dec. 31, 2025, except for the 400,000 American depositary shares that Chief Technology Officer Sheng Zhong is selling for personal financial reasons.Agora shares were up more than 3% in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK4551","API","TISI","API.AU","BK4503","BK4535","BK7103","BK4120"],"gpt_icon":1},{"id":"2487565661","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2487565661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487565661?lang=en_us&edition=full_marsco","pubTime":"2024-11-29 23:27","pubTimestamp":1732894063,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were higher on Friday morning, rising 0.6% to 2,039.94 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by computer hardware manufacturer Canaan  and game live streaming platform Huya , which advanced 14.8% and 3.8% respectively. They were followed by pharmaceutical company Beigene , which added 3.1%.The decliners from North Asia were led by software company Agora  and healthcare platform 111 , which fell 13.7% and 3.9% respectively.From South Asia, the gainers were led by telecoms company Telkom Indonesia  and pharmaceutical company Dr. Reddy's Laboratories , which rose 1.5% and 0.4% respectively.The decliners from South Asia were led by Indian banks HDFC  and ICICI , which fell 1.3% and 1.2% respectively.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2177674079.SGD","LU0348816934.USD","LU1102505762.USD","LU1804176565.USD","API","LU0918141887.USD","IBN","CAN.AU","LU0348744763.USD","LU0708995666.HKD","TLK","LU0823039010.USD","LU0251143458.SGD","BK4557","LU0528227936.USD","BK4548","LU0431992006.USD","HUYA","BK4596","BK7508","LU0828237940.HKD","BK4509","LU0348814723.USD","YI","LU0181495838.USD","LU1868837722.USD","BK4023","BK4551","LU0164881194.USD","BGNE","API.AU","BK7016","LU0868486357.SGD","LU0797268264.HKD","BK4566","HDB","LU0531971678.HKD","SG9999014005.SGD","BK4007","RDY.AU","BK4526","LU1854104046.USD","SG9999004220.SGD","IE00B7N09G41.SGD","LU1102505929.USD","IE00BYTNYM70.SGD","AFG","RDY","BK4504","CAN"],"gpt_icon":1},{"id":"2485409450","title":"Mastercard and JPMorgan team up for blockchain payment solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2485409450","media":"Grafa","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485409450?lang=en_us&edition=full_marsco","pubTime":"2024-11-22 11:45","pubTimestamp":1732247137,"startTime":"0","endTime":"0","summary":"Mastercard and JPMorgan have integrated their blockchain-powered platforms to streamline business-to-business cross-border payments.The partnership connects Mastercard’s Multi-Token Network  with JPMorgan’s Kinexys Digital Payments, enabling mutual customers to settle transactions through a unified application programming interface .The integration enhances payment availability, reduces time zone-related delays, and improves transparency and settlement speed.\"The value proposition of commercial transaction venues is enhanced by the availability of commercial bank payment rails that can natively integrate with any digital marketplace or platform,\" stated Naveen Mallela, co-head of Kinexys.MTN brings blockchain-based tools that complement Kinexys’s payment rail for real-time transfers.\"We are excited about this integration and the new use cases it will bring to life,\" stated Raj Dhamodharan, Mastercard’s executive vice president of blockchain and digital assets.Kinexys, formerly known as","market":null,"thumbnail":"https://images.grafa.com/grafa/media-business-news-mastercard-and-jpmorgan-team-up-for-blockchain-payment-solutions-317050-638678439371968620.jpeg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-business-news-mastercard-and-jpmorgan-team-up-for-blockchain-payment-solutions-317050-638678439371968620.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/business-news-mastercard-and-jpmorgan-team-up-for-blockchain-payment-solutions-317050?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7103","API.AU"],"gpt_icon":1},{"id":"2484918936","title":"Helix operator sentenced with $400M asset forfeiture","url":"https://stock-news.laohu8.com/highlight/detail?id=2484918936","media":"Grafa","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484918936?lang=en_us&edition=full_marsco","pubTime":"2024-11-18 12:32","pubTimestamp":1731904346,"startTime":"0","endTime":"0","summary":"The U.S. Department of Justice  announced that Larry Dean Harmon, 41, from Akron, Ohio, has been sentenced to three years in prison for operating Helix, a cryptocurrency mixer that facilitated over $300 million in Bitcoin  transactions between 2014 and 2017.Helix, linked to the darknet search engine Grams also run by Harmon, was commonly used by drug dealers to launder illicit earnings.“Helix was one of the most popular mixing services on the darknet and was highly sought after by online drug dealers who needed to launder their illicit proceeds,” the DOJ stated.Helix processed around 354,468 Bitcoin, valued at approximately $311 million at the time of the transactions, including transactions involving customers in the District of Columbia.\"In addition to his term in prison, Harmon was sentenced to three years of supervised release; a forfeiture money judgment in the amount of $311,145,854; and forfeiture of seized cryptocurrencies, real estate, and monetary assets valued at over $400 m","market":null,"thumbnail":"https://images.grafa.com/grafa/media-cryptocurrencies-helix-operator-sentenced-with--400m-asset-forfeiture-312680-638675011462109200.jpeg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-cryptocurrencies-helix-operator-sentenced-with--400m-asset-forfeiture-312680-638675011462109200.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/cryptocurrencies-helix-operator-sentenced-with--400m-asset-forfeiture-312680?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTC.USD.HKCC","BTC.USD.CC","API.AU","BK7103"],"gpt_icon":1},{"id":"2481511566","title":"Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481511566","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481511566?lang=en_us&edition=full_marsco","pubTime":"2024-11-08 12:23","pubTimestamp":1731039780,"startTime":"0","endTime":"0","summary":"The key reason the market is very excited about Sigma is its impending merger with Chemist Warehouse, now approved by the ACCC, to create a strong player in the space. Sigma's recent FY25 half-year result was solid, with 17% net revenue growth to $1.84 billion and 20.6% growth of EBIT to $18 million. It's clear the Wesfarmers' healthcare division is larger than Sigma. However, Sigma Healthcare will become a much more profitable business once combined with Chemist Warehouse, which recently reported its ownFY24 result, which showed $3.3 billion in revenue and, most importantly, $540 million in net profit. The combination of the two businesses is expected to unlock \"significant efficiencies\", with cost synergies estimated at an initial $60 million per a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/08/are-wesfarmers-or-sigma-shares-a-better-buy-in-the-pharmacy-arena/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4503","BK7103","SIG.AU","BK7153","XAO.AU","XJO.AU","API","EBIT","BK4551","BK4535","WES.AU","BK4023","API.AU","BK7511","XKO.AU","BK7041"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.api.net.au","stockEarnings":[{"period":"1week","weight":0.02},{"period":"1month","weight":0.02},{"period":"3month","weight":0.02},{"period":"6month","weight":0.02},{"period":"1year","weight":0.02},{"period":"ytd","weight":0.02}],"compareEarnings":[{"period":"1week","weight":-0.051},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.038},{"period":"6month","weight":0.0663},{"period":"1year","weight":0.1363},{"period":"ytd","weight":0.0449}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 488 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.36,"avgChangeRate":-0.02014},{"month":2,"riseRate":0.48,"avgChangeRate":0.016605},{"month":3,"riseRate":0.458333,"avgChangeRate":0.016811},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.035487},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.016481},{"month":6,"riseRate":0.52,"avgChangeRate":0.029906},{"month":7,"riseRate":0.32,"avgChangeRate":-0.01331},{"month":8,"riseRate":0.52,"avgChangeRate":0.030954},{"month":9,"riseRate":0.56,"avgChangeRate":0.045233},{"month":10,"riseRate":0.44,"avgChangeRate":-0.020848},{"month":11,"riseRate":0.68,"avgChangeRate":0.022791},{"month":12,"riseRate":0.36,"avgChangeRate":-0.005859}],"exchange":"ASX","name":"Australian Pharma Industries","nameEN":"Australian Pharma Industries"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.4","shortVersion":"4.32.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Australian Pharma Industries(API.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Australian Pharma Industries(API.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Australian Pharma Industries,API.AU,Australian Pharma Industries股票,Australian Pharma Industries股票老虎,Australian Pharma Industries股票老虎国际,Australian Pharma Industries行情,Australian Pharma Industries股票行情,Australian Pharma Industries股价,Australian Pharma Industries股市,Australian Pharma Industries股票价格,Australian Pharma Industries股票交易,Australian Pharma Industries股票购买,Australian Pharma Industries股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Australian Pharma Industries(API.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Australian Pharma Industries(API.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction